5412
S. P. Waters et al. / Tetrahedron Letters 47 (2006) 5409–5413
(b) Panzone, G.; Trani, A.; Ferrari, P.; Gastaldo, L.;
Colombo, L. J. Antibiot. 1997, 50, 665.
5. (a) Trani, A.; Dallanoce, C.; Ferarri, P.; Goldstein, B. P.;
Ripamonti, F.; Ciabatti, R. Il Farmaco 1996, 51, 503; (b)
Trani, A.; Kettenring, J.; Ripamonti, F.; Goldstein, B.;
Ciabatti, R. Il Farmaco 1993, 48, 637.
6. Ueno, T.; Takahashi, H.; Oda, M.; Mizunuma, M.;
Yokoyama, A.; Goto, Y.; Mizushina, Y.; Sakaguchi, K.;
Hayashi, H. Biochemistry 2000, 39, 5995.
7. Krillov, S.; Vitali, L. A.; Goldstein, B. P.; Monti, F.;
Semenkov, Y.; Makhno, V.; Ripa, S.; Pon, C. L.;
Gualerzi, C. O. RNA 1997, 3, 905.
8. (a) Qin, D.; Ren, R. X.; Siu, T.; Zheng, C.; Danishefsky, S.
J. Angew. Chem., Int. Ed. 2001, 40, 4709; (b) Siu, T.; Qin,
D.; Danishefsky, S. J. Angew. Chem., Int. Ed. 2001, 40,
4713.
9. (a) Capecchi, T.; de Koning, C. B.; Michael, J. P.
Tetrahedron Lett. 1998, 39, 5429; (b) Capecchi, T.; de
Koning, C. B.; Michael, J. P. J. Chem. Soc., Perkin Trans.
1 2000, 2681.
J = 11.9 Hz, 1H), 3.64 (d, J = 15.1 Hz, 1H), 3.58 (d,
J = 15.1 Hz, 1H), 3.15 (dd, J = 11.0, 17.3 Hz, 1H), 2.64
(dd, J = 7.8, 17.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) d
157.7, 156.4, 155.1, 136.9, 136.8, 130.4, 130.1, 128.6, 128.5
(2C), 128.2, 127.8 (2C), 127.1 (2C), 126.3, 124.7, 121.0,
120.9, 111.8, 111.5, 77.2, 70.0, 69.9, 44.3, 28.1; HRMS
(ESI) m/z calcd for C30H27NO3Na (MNa+) 472.1889,
found 472.1880.
1,4-Bis-(2-benzyloxy-phenyl)-4-hydroxy-butan-2-one (16).
To a solution of isoxazoline 15 (418 mg, 0.93 mmol) in
MeOH (50 mL) and H2O (5 mL) were added boric acid
(172 mg, 2.79 mmol) and Raney Ni (10 drops, 50% slurry
in H2O). After stirring under H2 (1 atm) for 5 h at rt, the
reaction mixture was filtered, poured into H2O (50 mL),
and extracted with CH2Cl2 (2 · 50 mL). The combined
organic layers were washed with brine (100 mL), dried
(Na2SO4), and concentrated. Purification of the residue by
flash chromatography (33% EtOAc/hexanes) afforded
keto-alcohol 16 (339 mg, 81% yield) as a clear colorless
1
oil: IR (neat) 3501 (br), 1710, 1602, 1015 cmꢀ1; H NMR
10. Tsang, K. T.; Brimble, M. A.; Bremner, J. B. Org. Lett.
2003, 5, 4425.
11. (a) Curran, D. P. J. Am. Chem. Soc. 1983, 105, 5826; (b)
Curran, D. P. J. Am. Chem. Soc. 1982, 104, 4024.
12. Obtained from Biosearch Italia SpA.
13. For reviews, see: (a) Anomeric Effects; Szarek, W. A.,
Horton, D., Eds. ACS Symposium Series 87; American
Chemical Society: Washington, DC, 1979; (b) Kirby, A. J.
The Anomeric Effect and Related Stereoelectronic Effects at
Oxygen; Springer: Berlin, 1983.
14. For a review of spiroketals including examples controlled
by hydrogen bonding, see: (a) Perron, F.; Albizati, K. F.
Chem. Rev. 1989, 89, 1617–1661; For a specific example of
hydrogen bonding being used to control spiroketal con-
figuration, see: (b) Ireland, R. E.; Habich, D.; Norbeck, D.
W. J. Am. Chem. Soc. 1985, 107, 3271–3278.
15. Spartan ’02 Windows, Wavefunction, Inc., 2001.
16. Harris, T. D.; Roth, G. P. J. Org. Chem. 1979, 44, 2004.
17. Wei, X.; Taylor, R. J. K. Tetrahedron Lett. 1996, 37,
4209.
18. (a) Kita, Y.; Takada, T.; Ibaraki, M.; Gyoten, M.;
Mihara, S.; Fujita, S.; Tohma, H. J. Org. Chem. 1996,
61, 223; (b) Dauzonne, D.; Royer, R. Synthesis 1984, 1054.
19. Sinhababu, A. K.; Borchardt, R. T. Tetrahedron Lett.
1983, 24, 227.
(500 MHz, CDCl3) d 7.41 (dd, J = 1.6, 7.5 Hz, 1H), 7.33–
7.24 (m, 10H), 7.19 (dd, J = 1.6, 7.4 Hz, 1H), 7.16 (dd,
J = 1.6, 7.5 Hz, 1H), 7.03 (dd, J = 1.6, 7.4 Hz, 1H), 6.94
(t, J = 7.4 Hz, 1H), 6.88 (t, J = 7.4 Hz, 1H), 6.85 (t,
J = 7.5 Hz, 1H), 6.83 (t, J = 7.5 Hz, 1H), 5.42 (dd,
J = 2.7, 9.0 Hz, 1H), 4.98 (s, 2H), 4.95 (s, 2H), 3.66 (d,
J = 16.1 Hz, 1H), 3.62 (d, J = 16.1 Hz, 1H), 3.53 (br s,
1H), 2.96 (dd, J = 2.7, 17.3 Hz, 1H), 2.72 (dd, J = 9.0,
17.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) d 209.6, 156.4,
154.8, 136.8 (2C), 131.3 (2C), 128.6, 128.5 (2C), 128.1,
127.9, 127.8, 127.2, 127.0, 126.6, 123.3, 121.1, 121.0, 111.8,
111.5, 70.0, 69.9, 65.6, 48.6, 45.5; HRMS (ESI) m/z calcd
for C30H28O4Na (MNa+) 475.1885, found 475.1874.
Spiroketal (17). To a solution of ketone 16 (200 mg,
0.442 mmol) in EtOH (10 mL) were added HCl (1 drop,
12 M) and Pd/C (40 mg, 10% Pd). After stirring under H2
(1 atm) for 12 h at rt, the reaction mixture was filtered and
concentrated. Purification of the residue by flash chroma-
tography (33% EtOAc/hexanes) afforded spiroketal 17
(82 mg, 78% yield) as a clear colorless oil: IR (neat) 3042,
1
2934, 1586 cmꢀ1; H NMR (500 MHz, CDCl3) d 7.25 (d,
J = 7.5 Hz. 1H), 7.16 (m, 3H), 6.94 (t, J = 7.5 Hz, 2H),
6.82 (d, J = 8.1 Hz, 2H), 3.49 (d, J = 16.5 Hz, 1H), 3.32
(d, J = 16.5 Hz, 1H), 3.28 (ddd, J = 6.2, 13.1, 16.8 Hz,
1H), 2.85 (ddd, J = 3.1, 6.2, 16.2 Hz, 1H), 2.35 (ddd,
J = 2.5, 6.2, 13.1 Hz, 1H), 2.24 (ddd, 6.2, 13.1, 13.1 Hz,
1H); 13C NMR (125 MHz, CDCl3) d 157.8, 152.3, 129.0,
128.1, 127.4, 125.3, 124.8, 121.3, 121.1, 121.0, 117.1, 109.8,
108.9, 41.8, 30.4, 21.9; HRMS (CI) m/z calcd for
C16H14O2 (M+) 238.0994, found 238.0997.
Spiroketals 18a and 18b. A suspension of keto-alcohol 16
(168 mg, 0.37 mmol) and 10% Pd/C (50 mg) in EtOAc
(10 mL) at rt was stirred under H2 (1 atm) overnight. The
reaction mixture was filtered through Celite and the
solvent removed. The residue was then dissolved in
CH2Cl2 (10 mL), and to this solution was added TsOH
(21 mg, 0.11 mmol). After stirring at rt for 45 min, the
reaction mixture was concentrated, and the residue puri-
fied by flash chromatography (25% EtOAc/hexanes) to
afford first spiroketal 18a (57 mg), followed by spiroketal
18b (25 mg) in 87% combined yield. Major diastereomer
18a: white solid; mp 126–127 ꢁC; IR (film) 3489 (br), 1586,
1212, 1065 cmꢀ1; 1H NMR (500 MHz, CDCl3) d 7.49 (dd,
J = 1.9, 7.5 Hz, 1H), 7.28 (d, J = 7.5 Hz, 1H), 7.24 (td,
J = 1.9, 7.5 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H), 7.06 (td,
J = 1.3, 7.5 Hz, 1H), 6.97 (td, J = 1.3, 7.5 Hz, 1H), 6.83
(d, J = 7.5 Hz, 1H), 6.77 (d, J = 7.5 Hz, 1H), 4.78 (ddd,
J = 1.7, 5.0, 11.8 Hz, 1H), 3.53 (d, J = 16.4 Hz, 1H), 3.50
(d, J = 11.8 Hz, 1H, OH), 3.38 (d, J = 16.4 Hz, 1H), 2.67
20. Kumar, G. A.; McAllister, M. A. J. Org. Chem. 1998, 63,
6968–6972.
21. Crystallographic data (excluding structure factors) have
been deposited with the Cambridge Crystallographic Data
Centre as supplementary publication number CCDC
604209. Copies of the data can be obtained, free of
charge, on application to CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK [fax: +44 (0)1223 336033 or
e-mail: deposit@ccdc.cam.ac.uk].
22. 4-(2-Benzyloxy-benzyl)-6-(2-benzyloxy-phenyl)-5,6-dihydro-
2H-[1,3] oxazine (15). To a solution of nitroalkane 14
(257 mg, 1.00 mmol) and styrene 12 (210 mg, 1.00 mmol)
in PhH (10 mL) at rt were added PhNCO (435 lL,
4.00 mmol) and Et3N (28 lL, 0.20 mmol). After 24 h, the
reaction mixture was filtered and the solvent removed.
Purification by flash chromatography (20% EtOAc/hex-
anes) afforded isoxazoline 15 (418 mg, 93% yield) as a
clear colorless oil: IR (neat) 1602, 1494, 1243, 1015 cmꢀ1
;
1H NMR (500 MHz, CDCl3) d 7.32 (d, J = 7.5 Hz, 1H),
7.27–7.19 (m, 10H), 7.11 (t, J = 7.5 Hz, 1H), 7.08 (d,
J = 7.5 Hz, 1H), 7.05 (d, J = 7.5 Hz, 1H), 6.83 (t,
J = 7.5 Hz, 1H), 6.80–6.77 (m, 3H), 5.69 (dd, J = 7.8,
11.0 Hz, 1H), 4.93 (d, J = 11.9 Hz, 1H), 4.92 (d, J =
11.2 Hz, 1H), 4.90 (d, J = 11.2 Hz, 1H), 4.89 (d,